#TCT2025 Late breaker PARTNER 3 Low Risk 7 Year #Sapien3#TAVR vs #SAVR showed no significant differences in composite endpoint, all-cause mortality, CV mortality, and low reintervention rates in both arms. Clinical valve thrombosis 2.8% TAVR vs 0.5% SAVR but similar BVF (valve failure) and reintervention.
Paper now online @NEJM and can download here:
https://t.co/nHJuyKUCaf
Nice @TCTMD article:
https://t.co/uAb3qy7Aeo
In EuroIntervention, @JoostDaemen explores the limitations of traditional clinical risk scores in predicting high-risk coronary plaques — and how OCT imaging provides insights that go beyond numbers.
👉👉👉https://t.co/2lraWbZPRS
#Cardiology#OCT#Imaging#Atherosclerosis #InterventionalCardiology #cardiotwitter
🆕 PARTNER 3 findings show similar rates of death, stroke or rehospitalization at 7 years among low-risk #TAVR or surgery patients with severe, symptomatic #vhdAS. Valve durability and patient-reported outcomes were also similar. More: https://t.co/6l5n7WRY6Y
#TCT2025
PCR Trials 📊 Book: six summaries from randomised clinical trials in interventional cardiology published between June and September 2025 now available.
🔗https://t.co/1LLZP2vDYl
(open access)
🟦Immediate or staged complete revascularisation during index admission for STEMI and multivessel disease • OPTION-STEMI
🟦FFR-guided complete or culprit-only revascularisation in NSTEMI and multivessel disease • SLIM
🟦Aspirin in CCS patients receiving oral anticoagulation • AQUATIC
🟦Early withdrawal of aspirin after PCI in ACS patients • NEO-MINDSET
🟦Ticagrelor and aspirin vs aspirin alone after CABG for ACS • TACSI
🟦Early aspirin discontinuation after PCI in low-risk acute MI • TARGET-FIRST
Selected by @robebyrne
#interventionalcardiology
I have translated into slides the topics and references used by the 2025 Guidelines Task Force on valvular heart disease to justify the recommendation for TAVI in patients aged 70 years or older. Their key argument is a certain degree of pragmatism — they consider age as a surrogate for life expectancy — and the presence of a relevant proportion of patients aged 70–75 years in at least four randomized trials. I know some people who agree with this approach and others who do not.
"I've done it!" On 16 September 1977, Andreas Grüntzig made history: he carried out the first #angioplasty, and changed the lives of millions of patients forever.
Standing on the shoulders of the giants that came before him, his vision and determination drove an entire new field of cardiology: Interventional Cardiology
Listen to this description of his incredible journey by Jean Marco, who knew him and was also a pioneer in the field. Jean Marco carried out his first angioplasty in 1979 and was inspired by Gruntzig's example to launch a LIVE demonstration Course in 1982.
This ultimately paved the way for the first PCR Course in 1989, founded with Jean Fajadet in Toulouse, and gave birth to PCR as we know it today.
From the legs to the coronaries: How Andreas Grüntzig reached his dream 📺 🎧 https://t.co/IZxUFqLjEm
(interviewed by @kiadeb87 )
More about the history of PCR here 🔗 https://t.co/eIAE7rz8zj
#interventionalcardiology #medicalhistory #interventionalcardiologist #cathlab
This study found that the hyperaemic stenosis resistance (HSR) index is more accurate than fractional flow reserve (FFR) and coronary flow reserve (CFR) in identifying ischemia-inducing coronary lesions. Additionally, an abnormal HSR measurement was a strong predictor of long-term target vessel failure. The authors conclude that incorporating combined pressure and flow measurements, as provided by HSR, could improve risk stratification of coronary lesions during invasive angiography.
https://t.co/2T7lZacgAY
Everything we have learned so far about the revascularization of non-culprit lesions in patients with acute myocardial infarction and multivessel disease... in 1 minute.
📌Oclusión de la orejuela auricular izquierda ‼️
🫀90% de los EVC cardioembolicos vienen de la orejuela izquierda
👽 4 morfologías: cactus, ala de pollo, manga de viento, coliflor( la más trombogenica)
🔖 Artículo a leer: PROTECT -AF, PREVAIL, PRAGUE
✅ Diferentes dispositivos: WATCHMAN FLX/ AMULET/ LAmbre/ Wavecrest/Conformal
‼️Tabla con indicacion de colocación ( 2A ACC )
‼️Tabla con los diferentes esquemas de anticoagulacion/antiagregacion